Panion & BF Biotech
Taipei, Taiwan· Est.
Taiwanese biotech delivering IVD diagnostics, hygiene solutions, and nephrology therapeutics.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Taiwanese biotech delivering IVD diagnostics, hygiene solutions, and nephrology therapeutics.
NephrologyAnti-AgingRespiratoryGastrointestinalDermatologyPain Management
Technology Platform
In‑house R&D platform integrating CMC, clinical, patent, regulatory, and commercialization expertise; Vstrip strip‑based IVD technology for rapid diagnostics; proprietary anti‑aging and nephrology drug discovery pipelines.
Opportunities
Expansion of Vstrip IVD kits into regional Asian markets and securing regulatory approvals for Nephoxil could drive significant revenue growth.
Risk Factors
Limited public data on clinical trial progress, financial performance, and competitive differentiation poses execution and market adoption risks.
Competitive Landscape
PBF competes with established IVD manufacturers and nephrology drug developers; its integrated R&D platform and diversified portfolio aim to differentiate it, though larger players have stronger scale and market reach.